Evidence map›Paper›PMID 36513927›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Labeling of Phospho-Specific Antibodies with oYo-Link® Epitope Tags for Multiplex Immunostaining.

Jingwen Niu, Jodi Hagen, Feifan Yu, Alexander E Kalyuzhny, Andrew Tsourkas

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jingwen NiuAlphaThera, Philadelphia, PA, USA.
Jodi HagenBio-Techne, Minneapolis, MN, USA.
Feifan YuAlphaThera, Philadelphia, PA, USA.
Alexander E KalyuzhnyBio-Techne, Minneapolis, MN, USA.
Andrew TsourkasDepartment of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA. atsourk@seas.upenn.edu.

Funding

Tools for the site-specific labeling and immobilization of antibodies for immunoassaysR44EB023750 · NIBIB · ALPHATHERA, INC. · PI YU, FEIFAN · 2018 to 2021
$2.2M
Modular approach for the delivery of antibodies into the cytoplasm of cellsR01CA241661 · NCI · UNIVERSITY OF PENNSYLVANIA · PI TSOURKAS, ANDREW · 2019 to 2023
$1.8M
NCI NIH HHS R01 CA241661NIBIB NIH HHS R44 EB023750
6 · The paper itself

Abstract

Spatial proteomics has recently garnered significant interest, as it offers to provide unprecedented insight into biological processes in both health and disease, by connecting protein expression patterns from the subcellular level to the tissue or even organism level. These high-content approaches generally rely on a high degree of multiplexing, whereby multiple proteins can be detected simultaneously. The most versatile multiplexing approaches utilize antibodies to confer specificity for various intracellular proteins of interest. Therefore, these methods must be able to differentiate many antibodies at once. In this chapter, we describe a simple and rapid approach to labeling antibodies with distinct epitope tags in a site-specific manner. This allows multiple antibodies, even from the same host species, to be uniquely identified and detected and offers a simple approach for spatial proteomic applications.

Indexed as

AntibodiesProteomicsAntibodies, Phospho-SpecificEpitopesProteinsAntibodiesAntibodies, Phospho-SpecificEpitopesProteinsAntibody conjugationEpitope tagImmunocytochemistryMultiplexingSite-specific labelingSpatial proteomics

Identifiers

PMID36513927
PMCPMC10730302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.